Page 1

הבורסה TEL AVIV לניירות ערך א STOC תל אביב EXCHANGE November 22 , 2021 400730.docx THE TEL - AVIV STOCK EXCHANGE LTD . REPORTED THIRD QUARTER 2021 RESULTS November 22 , 2021 ( Tel Aviv ) -Tel Aviv Stock Exchange Ltd ( TASE : TASE ) today announced its financial results for the third quarter ended September 30 , 2021.1 General Coronavirus morbidity rate trends diversified in the first nine months of 2021. The beginning of the period was characterized by the gradual lifting of the restrictions that were imposed on the business sector following the coronavirus outbreak in 2020 , arriving at the second quarter of 2021 with almost no restrictions . At the end of the second quarter , the outbreak of the Delta variant caused morbidity rates to rise well into the third quarter . The Government's policy in handling this outbreak was to maintain the continuity of economic , educational and cultural activities alongside the implementation of steps for the mitigation of the outbreak . Within this framework , specific restrictions were set for the various activities , testing was expanded , and a campaign was launched for " booster " shots for those previously vaccinated and for encouraging vaccination among the non - vaccinated . Following these steps , morbidity rates started to drop by the end of the third quarter . In the first nine months of 2021 , the capital market in Israel was characterized by an increase in the number of companies that carried out an IPO on TASE ( 84 companies ) , from all the sectors that are traded on TASE , alongside an appreciation in the value of the assets traded on TASE since the beginning of the year . The average trading volumes in the third quarter of 2021 were similar to the average trading volumes in the corresponding quarter last year , whereas the average trading volumes in the reported period were lower than those recorded in the corresponding period last year , due to the uncertainty that prevailed at the time on the backdrop of the coronavirus outbreak and its implications . The changes in morbidity trends that took place in the third quarter of 2021 did not materially affect the aforementioned trends concerning the value of the assets traded on TASE and the trading volumes . Based on the trading data and the activity volumes of the Company in the third quarter of 2021 , the Company believes that , provided that the Government continues to maintain regular activities in the market , as described above , no material adverse effect on the activity of the Company is expected , even in the event of a rise in morbidity rates in the foreseeable future . 1 1. The Board of Directors of TASE today approved the Consolidated Financial Statement as of September 30 , 2021. The consolidated financial statements of the Company were prepared in accordance with IFRS . This is an English translation of parts of the information included in the approved financial statements . In the event of any discrepancy between the original Hebrew and the translation to English , the Hebrew version alone will prevail . The consolidated financial statements in the English Version will be published on the website by the end of December 2021 .